{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:45:30Z","timestamp":1787852730794,"version":"build-2784847793"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health & Welfare, Republic of Korea","award":["RS-2021-KH119931"],"award-info":[{"award-number":["RS-2021-KH119931"]}]},{"name":"Korea government","award":["IRIS RS-2024-00340590"],"award-info":[{"award-number":["IRIS RS-2024-00340590"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-38049-x","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:35:46Z","timestamp":1770723346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The influence of menopausal phase on atrial fibrillation risk in steatotic liver disease patients: a nationwide cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"JungMin","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung\u2011Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So\u2011Ryoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jeong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seil","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregoryn Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eue\u2011Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"38049_CR1","doi-asserted-by":"publisher","first-page":"100786","DOI":"10.1016\/j.lanepe.2023.100786","volume":"37","author":"D Linz","year":"2024","unstructured":"Linz, D. et al. Atrial fibrillation: epidemiology, screening and digital health. Lancet Reg. Health Eur. 37, 100786. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100786 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"38049_CR2","doi-asserted-by":"publisher","first-page":"100784","DOI":"10.1016\/j.lanepe.2023.100784","volume":"37","author":"E Shantsila","year":"2024","unstructured":"Shantsila, E., Choi, E. K., Lane, D. A., Joung, B. & Lip, G. Y. H. Atrial fibrillation: comorbidities, lifestyle, and patient factors. Lancet Reg. Health Eur. 37, 100784. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100784 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"38049_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","volume":"20","author":"AD Elliott","year":"2023","unstructured":"Elliott, A. D., Middeldorp, M. E., Van Gelder, I. C., Albert, C. M. & Sanders, P. Epidemiology and modifiable risk factors for atrial fibrillation. Nat. Rev. Cardiol. 20, 404\u2013417. https:\/\/doi.org\/10.1038\/s41569-022-00820-8 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"38049_CR4","doi-asserted-by":"publisher","unstructured":"Lu, Z. et al. Association between sex-specific risk factors and risk of new-onset atrial fibrillation among women. JAMA Netw Open 5, e2229716 (2022). https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.29716","DOI":"10.1001\/jamanetworkopen.2022.29716"},{"key":"38049_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.clnu.2024.11.016","volume":"43","author":"XD Zhou","year":"2024","unstructured":"Zhou, X. D. et al. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15\u201339, 1990\u20132021. Clin. Nutr. 43, 391\u2013404. https:\/\/doi.org\/10.1016\/j.clnu.2024.11.016 (2024).","journal-title":"Clin. Nutr."},{"key":"38049_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","volume":"17","author":"XD Zhou","year":"2023","unstructured":"Zhou, X. D. et al. An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatol. Int. 17, 773\u2013791. https:\/\/doi.org\/10.1007\/s12072-023-10543-8 (2023).","journal-title":"Hepatol. Int."},{"key":"38049_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/hepr.14020","volume":"54","author":"M Nakano","year":"2024","unstructured":"Nakano, M., Kawaguchi, M., Kawaguchi, T. & Yoshiji, H. Profiles associated with significant hepatic fibrosis consisting of Alanine aminotransferase\u2009>\u200930 U\/L, exercise habits, and metabolic dysfunction-associated steatotic liver disease. Hepatol. Res. 54, 655\u2013666. https:\/\/doi.org\/10.1111\/hepr.14020 (2024).","journal-title":"Hepatol. Res."},{"key":"38049_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/hepr.14170","volume":"55","author":"T Cho","year":"2025","unstructured":"Cho, T. et al. Metabolic dysfunction-associated steatotic liver disease is a risk factor for gallstones: A multicenter cohort study. Hepatol. Res. 55, 663\u2013674. https:\/\/doi.org\/10.1111\/hepr.14170 (2025). https:\/\/doi.org:","journal-title":"Hepatol. Res."},{"key":"38049_CR9","doi-asserted-by":"publisher","unstructured":"Tanaka, H. et al. MetALD was a more notable independent risk factor for reflux esophagitis than MASLD: A multicenter cohort study using directed acyclic graphs. Hepatol. Res. https:\/\/doi.org\/10.1111\/hepr.70028","DOI":"10.1111\/hepr.70028"},{"key":"38049_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher, G., Valenti, L. & Byrne, C. D. Metabolic Dysfunction-Associated steatotic liver disease. N Engl. J. Med. 393, 683\u2013698. https:\/\/doi.org\/10.1056\/NEJMra2412865 (2025).","journal-title":"N Engl. J. Med."},{"key":"38049_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","volume":"73","author":"EP Stahl","year":"2019","unstructured":"Stahl, E. P. et al. Nonalcoholic fatty liver disease and the heart: JACC State-of-the-Art review. J. Am. Coll. Cardiol. 73, 948\u2013963. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.050 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"38049_CR12","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1016\/s0140-6736(21)00684-x","volume":"397","author":"B Vogel","year":"2021","unstructured":"Vogel, B. et al. The lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet 397, 2385\u20132438. https:\/\/doi.org\/10.1016\/s0140-6736(21)00684-x (2021).","journal-title":"Lancet"},{"key":"38049_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00535-025-02242-y","volume":"60","author":"T Tsutsumi","year":"2025","unstructured":"Tsutsumi, T. et al. Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis. J. Gastroenterol. 60, 891\u2013904. https:\/\/doi.org\/10.1007\/s00535-025-02242-y (2025).","journal-title":"J. Gastroenterol."},{"key":"38049_CR14","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","volume":"22","author":"M Kalligeros","year":"2024","unstructured":"Kalligeros, M. et al. Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the united states: NHANES 2017\u20132020. Clin. Gastroenterol. Hepatol. 22, 1330\u20131332e1334. https:\/\/doi.org\/10.1016\/j.cgh.2023.11.003 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"38049_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","volume":"46","author":"S Cheol Seong","year":"2017","unstructured":"Cheol Seong, S. et al. Data resource profile: the National health information database of the National health insurance service in South Korea. Int. J. Epidemiol. 46, 799\u2013800. https:\/\/doi.org\/10.1093\/ije\/dyw253 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"38049_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5124\/jkma.2010.53.5.363","volume":"53","author":"WC Lee","year":"2010","unstructured":"Lee, W. C. & Lee, S. Y. National health screening program of Korea. Jkma 53, 363\u2013370. https:\/\/doi.org\/10.5124\/Jkma.2010.53.5.363 (2010).","journal-title":"Jkma"},{"key":"38049_CR17","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/hep.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986. https:\/\/doi.org\/10.1097\/hep.0000000000000520 (2023).","journal-title":"Hepatology"},{"key":"38049_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230x-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33. https:\/\/doi.org\/10.1186\/1471-230x-6-33 (2006).","journal-title":"BMC Gastroenterol."},{"key":"38049_CR19","doi-asserted-by":"publisher","first-page":"19224","DOI":"10.1038\/s41598-020-75822-y","volume":"10","author":"SR Lee","year":"2020","unstructured":"Lee, S. R. et al. Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study. Sci. Rep. 10, 19224. https:\/\/doi.org\/10.1038\/s41598-020-75822-y (2020).","journal-title":"Sci. Rep."},{"key":"38049_CR20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","volume":"50","author":"EK Choi","year":"2020","unstructured":"Choi, E. K. Cardiovascular research using the Korean National health information database. Korean Circ. J. 50, 754\u2013772. https:\/\/doi.org\/10.4070\/kcj.2020.0171 (2020).","journal-title":"Korean Circ. J."},{"key":"38049_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.2215\/cjn.01860217","volume":"12","author":"N Bansal","year":"2017","unstructured":"Bansal, N. et al. eGFR and albuminuria in relation to risk of incident atrial fibrillation: A Meta-Analysis of the Jackson heart study, the Multi-Ethnic study of Atherosclerosis, and the cardiovascular health study. Clin. J. Am. Soc. Nephrol. 12, 1386\u20131398. https:\/\/doi.org\/10.2215\/cjn.01860217 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"38049_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.hrthm.2019.07.006","volume":"17","author":"SR Lee","year":"2020","unstructured":"Lee, S. R., Choi, E. K., Han, K. D., Lee, S. H. & Oh, S. Effect of the variability of blood pressure, glucose level, total cholesterol level, and body mass index on the risk of atrial fibrillation in a healthy population. Heart Rhythm. 17, 12\u201319. https:\/\/doi.org\/10.1016\/j.hrthm.2019.07.006 (2020).","journal-title":"Heart Rhythm"},{"key":"38049_CR23","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/heartjnl-2014-305756","volume":"100","author":"A Alonso","year":"2014","unstructured":"Alonso, A. et al. Circulating levels of liver enzymes and incidence of atrial fibrillation: the atherosclerosis risk in communities cohort. Heart 100, 1511\u20131516. https:\/\/doi.org\/10.1136\/heartjnl-2014-305756 (2014).","journal-title":"Heart"},{"key":"38049_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/gutjnl-2023-331003","volume":"73","author":"HH Lee","year":"2024","unstructured":"Lee, H. H. et al. Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease. Gut 73, 533\u2013540. https:\/\/doi.org\/10.1136\/gutjnl-2023-331003 (2024).","journal-title":"Gut"},{"key":"38049_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong, V. W., Ekstedt, M., Wong, G. L. & Hagstr\u00f6m, H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J. Hepatol. 79, 842\u2013852. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.036 (2023).","journal-title":"J. Hepatol."},{"key":"38049_CR26","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams, L. A., Anstee, Q. M., Tilg, H. & Targher, G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66, 1138\u20131153. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884 (2017).","journal-title":"Gut"},{"key":"38049_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12933-023-02070-5","volume":"22","author":"TG Simon","year":"2023","unstructured":"Simon, T. G. et al. Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study. Cardiovasc. Diabetol. 22, 343. https:\/\/doi.org\/10.1186\/s12933-023-02070-5 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"38049_CR28","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.mayocp.2023.12.025","volume":"99","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul, P. et al. Metabolic syndrome and metabolic Dysfunction-Associated steatotic liver disease in premenopausal women: global trends and projections to 2040. Mayo Clin. Proc. 99, 1615\u20131628. https:\/\/doi.org\/10.1016\/j.mayocp.2023.12.025 (2024).","journal-title":"Mayo Clin. Proc."},{"key":"38049_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/gme.0000000000002133","volume":"30","author":"A Jaroenlapnopparat","year":"2023","unstructured":"Jaroenlapnopparat, A. et al. Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Menopause 30, 348\u2013354. https:\/\/doi.org\/10.1097\/gme.0000000000002133 (2023).","journal-title":"Menopause"},{"key":"38049_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","volume":"21","author":"SH Park","year":"2006","unstructured":"Park, S. H. et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21, 138\u2013143. https:\/\/doi.org\/10.1111\/j.1440-1746.2005.04086.x (2006).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"38049_CR31","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.26761","volume":"59","author":"JD Yang","year":"2014","unstructured":"Yang, J. D. et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 59, 1406\u20131414. https:\/\/doi.org\/10.1002\/hep.26761 (2014).","journal-title":"Hepatology"},{"key":"38049_CR32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/oby.21879","volume":"25","author":"TG Simon","year":"2017","unstructured":"Simon, T. G., Bamira, D. G., Chung, R. T., Weiner, R. B. & Corey, K. E. Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction. Obes. (Silver Spring). 25, 1313\u20131316. https:\/\/doi.org\/10.1002\/oby.21879 (2017).","journal-title":"Obes. (Silver Spring)"},{"key":"38049_CR33","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jhep.2019.01.035","volume":"70","author":"D Houghton","year":"2019","unstructured":"Houghton, D. et al. The degree of hepatic steatosis associates with impaired cardiac and autonomic function. J. Hepatol. 70, 1203\u20131213. https:\/\/doi.org\/10.1016\/j.jhep.2019.01.035 (2019).","journal-title":"J. Hepatol."},{"key":"38049_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/hep.27869","volume":"62","author":"LB VanWagner","year":"2015","unstructured":"VanWagner, L. B. et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study. Hepatology 62, 773\u2013783. https:\/\/doi.org\/10.1002\/hep.27869 (2015).","journal-title":"Hepatology"},{"key":"38049_CR35","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/heartjnl-2013-305099","volume":"100","author":"NH Kim","year":"2014","unstructured":"Kim, N. H. et al. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart 100, 938\u2013943. https:\/\/doi.org\/10.1136\/heartjnl-2013-305099 (2014).","journal-title":"Heart"},{"key":"38049_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0161734615595015","volume":"38","author":"O Ozveren","year":"2016","unstructured":"Ozveren, O. et al. Doppler tissue evaluation of atrial conduction properties in patients with Non-alcoholic Fatty-liver disease. Ultrason. Imaging. 38, 225\u2013235. https:\/\/doi.org\/10.1177\/0161734615595015 (2016).","journal-title":"Ultrason. Imaging"},{"key":"38049_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/echo.14229","volume":"36","author":"RA Mahfouz","year":"2019","unstructured":"Mahfouz, R. A., Gouda, M., Galal, I. & Ghareb, M. S. Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation. Echocardiography 36, 249\u2013256. https:\/\/doi.org\/10.1111\/echo.14229 (2019).","journal-title":"Echocardiography"},{"key":"38049_CR38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/cvr\/cvx012","volume":"113","author":"K Nishida","year":"2017","unstructured":"Nishida, K. & Otsu, K. Inflammation and metabolic cardiomyopathy. Cardiovasc. Res. 113, 389\u2013398. https:\/\/doi.org\/10.1093\/cvr\/cvx012 (2017).","journal-title":"Cardiovasc. Res."},{"key":"38049_CR39","doi-asserted-by":"publisher","first-page":"1360974","DOI":"10.3389\/fphar.2024.1360974","volume":"15","author":"B Zhong","year":"2024","unstructured":"Zhong, B. et al. Identification of key genes increasing susceptibility to atrial fibrillation in nonalcoholic fatty liver disease and the potential mechanisms: mitochondrial dysfunction and systemic inflammation. Front. Pharmacol. 15, 1360974. https:\/\/doi.org\/10.3389\/fphar.2024.1360974 (2024).","journal-title":"Front. Pharmacol."},{"key":"38049_CR40","doi-asserted-by":"publisher","first-page":"e035710","DOI":"10.1161\/jaha.124.035710","volume":"13","author":"SG Shitole","year":"2024","unstructured":"Shitole, S. G. et al. Assessment of inflammatory biomarkers and incident atrial fibrillation in older adults. J. Am. Heart Assoc. 13, e035710. https:\/\/doi.org\/10.1161\/jaha.124.035710 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"38049_CR41","doi-asserted-by":"publisher","first-page":"107602962311650","DOI":"10.1177\/10760296231165055","volume":"29","author":"A Odeh","year":"2023","unstructured":"Odeh, A. et al. Interrelationship between inflammatory biomarkers and collagen remodeling proteins in atrial fibrillation. Clin. Appl. Thromb. Hemost. 29, 10760296231165055. https:\/\/doi.org\/10.1177\/10760296231165055 (2023).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"38049_CR42","doi-asserted-by":"publisher","first-page":"e006557","DOI":"10.1161\/circep.118.006557","volume":"11","author":"DA Duprez","year":"2018","unstructured":"Duprez, D. A. et al. Collagen biomarkers and incidence of new onset of atrial fibrillation in subjects with no overt cardiovascular disease at baseline: the Multi-Ethnic study of atherosclerosis. Circ. Arrhythm. Electrophysiol. 11, e006557. https:\/\/doi.org\/10.1161\/circep.118.006557 (2018).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"38049_CR43","doi-asserted-by":"publisher","unstructured":"Ionin, V. A. et al. Galectin-3, N-terminal propeptides of type I and III Procollagen in patients with atrial fibrillation and metabolic syndrome. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21165689 (2020).","DOI":"10.3390\/ijms21165689"},{"key":"38049_CR44","doi-asserted-by":"publisher","first-page":"13771","DOI":"10.1038\/s41598-023-40689-2","volume":"13","author":"WK Jeon","year":"2023","unstructured":"Jeon, W. K. et al. Association between the accumulation of elevated serum \u03b3-glutamyltransferase level and risk of atrial fibrillation: a nationwide cohort study. Sci. Rep. 13, 13771. https:\/\/doi.org\/10.1038\/s41598-023-40689-2 (2023).","journal-title":"Sci. Rep."},{"key":"38049_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10654-017-0232-4","volume":"32","author":"D Aune","year":"2017","unstructured":"Aune, D. et al. Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur. J. Epidemiol. 32, 181\u2013192. https:\/\/doi.org\/10.1007\/s10654-017-0232-4 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"38049_CR46","doi-asserted-by":"publisher","first-page":"e001211","DOI":"10.1161\/jaha.114.001211","volume":"3","author":"A Alonso","year":"2014","unstructured":"Alonso, A. et al. Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic study of atherosclerosis and the Framingham heart study. J. Am. Heart Assoc. 3, e001211. https:\/\/doi.org\/10.1161\/jaha.114.001211 (2014).","journal-title":"J. Am. Heart Assoc."},{"key":"38049_CR47","doi-asserted-by":"publisher","first-page":"102292","DOI":"10.1016\/j.eclinm.2023.102292","volume":"65","author":"JH Moon","year":"2023","unstructured":"Moon, J. H., Jeong, S., Jang, H., Koo, B. K. & Kim, W. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. EClinicalMedicine 65, 102292. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102292 (2023).","journal-title":"EClinicalMedicine"},{"key":"38049_CR48","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.jacc.2016.08.074","volume":"68","author":"A Voskoboinik","year":"2016","unstructured":"Voskoboinik, A., Prabhu, S., Ling, L. H., Kalman, J. M. & Kistler, P. M. Alcohol and atrial fibrillation: A sobering review. J. Am. Coll. Cardiol. 68, 2567\u20132576. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.074 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"38049_CR49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0022-0736(78)80120-4","volume":"11","author":"L Gould","year":"1978","unstructured":"Gould, L., Reddy, C. V., Becker, W., Oh, K. C. & Kim, S. G. Electrophysiologic properties of alcohol in man. J. Electrocardiol. 11, 219\u2013226. https:\/\/doi.org\/10.1016\/s0022-0736(78)80120-4 (1978).","journal-title":"J. Electrocardiol."},{"key":"38049_CR50","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/s0002-9149(98)00299-9","volume":"82","author":"T M\u00e4ki","year":"1998","unstructured":"M\u00e4ki, T. et al. Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation. Am. J. Cardiol. 82, 317\u2013322. https:\/\/doi.org\/10.1016\/s0002-9149(98)00299-9 (1998).","journal-title":"Am. J. Cardiol."},{"key":"38049_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/alcalc\/agh085","volume":"39","author":"NS Aberle","year":"2004","unstructured":"Aberle, N. S. 2, Burd, L., Zhao, B. H., Ren, J. & nd, & Acetaldehyde-induced cardiac contractile dysfunction May be alleviated by vitamin B1 but not by vitamins B6 or B12. Alcohol Alcohol. 39, 450\u2013454. https:\/\/doi.org\/10.1093\/alcalc\/agh085 (2004).","journal-title":"Alcohol Alcohol"},{"key":"38049_CR52","doi-asserted-by":"publisher","unstructured":"El Khoudary, S. R. et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American heart association. Circulation 142, e506-e532 (2020). https:\/\/doi.org\/10.1161\/cir.0000000000000912","DOI":"10.1161\/cir.0000000000000912"},{"key":"38049_CR53","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1016\/s2468-2667(19)30155-0","volume":"4","author":"D Zhu","year":"2019","unstructured":"Zhu, D. et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public. Health. 4, e553\u2013e564. https:\/\/doi.org\/10.1016\/s2468-2667(19)30155-0 (2019).","journal-title":"Lancet Public. Health"},{"key":"38049_CR54","doi-asserted-by":"publisher","first-page":"e007428","DOI":"10.1161\/circep.119.007428","volume":"12","author":"S Yang","year":"2019","unstructured":"Yang, S. et al. Association of total reproductive years with incident atrial Fibrillation, and subsequent ischemic stroke in women with natural menopause. Circ. Arrhythm. Electrophysiol. 12, e007428. https:\/\/doi.org\/10.1161\/circep.119.007428 (2019).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"38049_CR55","doi-asserted-by":"publisher","unstructured":"Kami\u0144ska, M. S. et al. Menopause predisposes women to increased risk of cardiovascular disease. J. Clin. Med. 12 https:\/\/doi.org\/10.3390\/jcm12227058 (2023).","DOI":"10.3390\/jcm12227058"},{"key":"38049_CR56","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12916-016-0762-8","volume":"15","author":"AC de Kat","year":"2017","unstructured":"de Kat, A. C. et al. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med. 15, 2. https:\/\/doi.org\/10.1186\/s12916-016-0762-8 (2017).","journal-title":"BMC Med."},{"key":"38049_CR57","doi-asserted-by":"publisher","unstructured":"Gurka, M. J., Vishnu, A., Santen, R. J. & DeBoer, M. D. Progression of metabolic syndrome severity during the menopausal transition. J. Am. Heart Assoc. 5 https:\/\/doi.org\/10.1161\/jaha.116.003609 (2016).","DOI":"10.1161\/jaha.116.003609"},{"key":"38049_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.metabol.2008.09.030","volume":"58","author":"RM Franklin","year":"2009","unstructured":"Franklin, R. M., Ploutz-Snyder, L. & Kanaley, J. A. Longitudinal changes in abdominal fat distribution with menopause. Metabolism 58, 311\u2013315. https:\/\/doi.org\/10.1016\/j.metabol.2008.09.030 (2009).","journal-title":"Metabolism"},{"key":"38049_CR59","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ogc.2018.07.006","volume":"45","author":"SR El Khoudary","year":"2018","unstructured":"El Khoudary, S. R. & Thurston, R. C. Cardiovascular implications of the menopause transition: endogenous sex hormones and vasomotor symptoms. Obstet. Gynecol. Clin. North. Am. 45, 641\u2013661. https:\/\/doi.org\/10.1016\/j.ogc.2018.07.006 (2018).","journal-title":"Obstet. Gynecol. Clin. North. Am."},{"key":"38049_CR60","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.immuni.2023.10.008","volume":"56","author":"JP Hoffmann","year":"2023","unstructured":"Hoffmann, J. P., Liu, J. A., Seddu, K. & Klein, S. L. Sex hormone signaling and regulation of immune function. Immunity 56, 2472\u20132491. https:\/\/doi.org\/10.1016\/j.immuni.2023.10.008 (2023).","journal-title":"Immunity"},{"key":"38049_CR61","doi-asserted-by":"publisher","first-page":"2295429","DOI":"10.1080\/19490976.2023.2295429","volume":"16","author":"TL Cross","year":"2024","unstructured":"Cross, T. L. et al. Gut Microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction. Gut Microbes. 16, 2295429. https:\/\/doi.org\/10.1080\/19490976.2023.2295429 (2024).","journal-title":"Gut Microbes"},{"key":"38049_CR62","doi-asserted-by":"publisher","first-page":"11806","DOI":"10.1073\/pnas.1205797109","volume":"109","author":"A Villa","year":"2012","unstructured":"Villa, A. et al. Tetradian Oscillation of Estrogen receptor \u03b1 is necessary to prevent liver lipid deposition. Proc. Natl. Acad. Sci. U S A. 109, 11806\u201311811. https:\/\/doi.org\/10.1073\/pnas.1205797109 (2012).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"38049_CR63","doi-asserted-by":"publisher","unstructured":"Xiang, D., Liu, Y., Zhou, S., Zhou, E. & Wang, Y. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress. Oxid. Med. Cell Longev. 5523516 (2021).https:\/\/doi.org\/10.1155\/2021\/5523516","DOI":"10.1155\/2021\/5523516"},{"key":"38049_CR64","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1038\/s41591-023-02553-8","volume":"29","author":"A Cherubini","year":"2023","unstructured":"Cherubini, A. et al. Interaction between Estrogen receptor-\u03b1 and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women. Nat. Med. 29, 2643\u20132655. https:\/\/doi.org\/10.1038\/s41591-023-02553-8 (2023).","journal-title":"Nat. Med."},{"key":"38049_CR65","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1113\/jp285126","volume":"602","author":"KG Schwarz","year":"2024","unstructured":"Schwarz, K. G., Vicencio, S. C., Inestrosa, N. C. & Villaseca, P. Del Rio, R. Autonomic nervous system dysfunction throughout menopausal transition: A potential mechanism underpinning cardiovascular and cognitive alterations during female ageing. J. Physiol. 602, 263\u2013280. https:\/\/doi.org\/10.1113\/jp285126 (2024).","journal-title":"J. Physiol."},{"key":"38049_CR66","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/gme.0000000000001815","volume":"28","author":"W Ying","year":"2021","unstructured":"Ying, W. et al. Associations between menopause, cardiac remodeling, and diastolic function: the CARDIA study. Menopause 28, 1166\u20131175. https:\/\/doi.org\/10.1097\/gme.0000000000001815 (2021).","journal-title":"Menopause"},{"key":"38049_CR67","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/j.1478-3231.2011.02580.x","volume":"31","author":"JH Kim","year":"2011","unstructured":"Kim, J. H., Kwon, S. Y., Lee, S. W. & Lee, C. H. Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population. Liver Int. 31, 1600\u20131601. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02580.x (2011).","journal-title":"Liver Int."},{"key":"38049_CR68","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler, E. M. et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin. Gastroenterol. Hepatol. 11, 1201\u20131204. https:\/\/doi.org\/10.1016\/j.cgh.2012.12.031 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"38049_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.02.013","author":"MH Kim","year":"2025","unstructured":"Kim, M. H. et al. Racial differences and similarities in atrial fibrillation epidemiology and risk factors in UK biobank and Korean NHIS-HEALS cohort studies. Heart Rhythm. https:\/\/doi.org\/10.1016\/j.hrthm.2025.02.013 (2025).","journal-title":"Heart Rhythm"},{"key":"38049_CR70","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1055\/a-2278-8769","volume":"124","author":"DS Kang","year":"2024","unstructured":"Kang, D. S. et al. Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study. Thromb. Haemost. 124, 883\u2013892. https:\/\/doi.org\/10.1055\/a-2278-8769 (2024).","journal-title":"Thromb. Haemost"},{"key":"38049_CR71","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1161\/circulationaha.113.002449","volume":"128","author":"TA Dewland","year":"2013","unstructured":"Dewland, T. A., Olgin, J. E., Vittinghoff, E. & Marcus, G. M. Incident atrial fibrillation among Asians, Hispanics, blacks, and Whites. Circulation 128, 2470\u20132477. https:\/\/doi.org\/10.1161\/circulationaha.113.002449 (2013).","journal-title":"Circulation"},{"key":"38049_CR72","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.hrthm.2018.05.019","volume":"15","author":"FE Ugowe","year":"2018","unstructured":"Ugowe, F. E., Jackson, L. R. 2, Thomas, K. L. & nd & Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review. Heart Rhythm. 15, 1337\u20131345. https:\/\/doi.org\/10.1016\/j.hrthm.2018.05.019 (2018).","journal-title":"Heart Rhythm"},{"key":"38049_CR73","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ahj.2016.03.004","volume":"176","author":"F Rodriguez","year":"2016","unstructured":"Rodriguez, F. et al. Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: findings from the women\u2019s health initiative. Am. Heart J. 176, 70\u201377. https:\/\/doi.org\/10.1016\/j.ahj.2016.03.004 (2016).","journal-title":"Am. Heart J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38049-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38049-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38049-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:01:49Z","timestamp":1772701309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38049-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38049"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38049-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SRL: Speaking fees from Bayer, BMS\/Pfizer, Biosense Webster, Daiichi-Sankyo, Sanofi-Aventis, Daewoong Pharmaceutical Co., Samjinpharm, Seers Technology, Biotronik, Boston Scientific, and Medtronic. Consultant for Biosense Webster. EKC: Research grants or speaking fees from Abbott, Bayer, BMS\/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co., Daiichi-Sankyo, DeepQure, Dreamtech Co., Ltd., Jeil. GYHL: Consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Anthos, and Daiichi-Sankyo. GYHL is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union\u2019s Horizon 2020 research and innovation program under grant agreement No. 899871. No personal fees were received. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8205"}}